Journal of Nutrition Bio-Serv Delivering Solutions. . .

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, C. W.
Right arrow Articles by Curran, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, C. W.
Right arrow Articles by Curran, I. H.
© 2007 The American Society for Nutrition J. Nutr. 137:1-6, January 2007

Biochemical, Molecular, and Genetic Mechanisms

Dietary Soy Protein Isolate Modifies Hepatic Retinoic Acid Receptor-ß Proteins and Inhibits Their DNA Binding Activity in Rats1,2

Chao Wu Xiao3,5,*, Jie Mei3, Wenxin Huang3, Carla Wood3, Mary R. L'Abbé3, G. Sarwar Gilani3, Gerard M. Cooke4,5 and Ivan H. Curran4

3 Nutrition Research Division, 4 Toxicology Research Division, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, Ottawa, ON, Canada K1A 0L2 and 5 Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

* To whom correspondence should be addressed. E-mail: chaowu_xiao{at}hc-sc.gc.ca.


   ABSTRACT
TOP
 ABSTRACT
Introduction
 Materials and Methods
 Results
 Discussion
 LITERATURE CITED
 
Retinoic acid receptors (RAR) belong to the same nuclear receptor superfamily as thyroid hormone receptors (TR) that were previously shown to be modulated by dietary soy protein isolate (SPI). This study has examined the effect of dietary SPI and isoflavones (ISF) on hepatic RAR gene expression and DNA binding activity. In Expt. 1, Sprague-Dawley rats were fed diets containing 20% casein or 20% alcohol-washed SPI in the absence or presence of increasing amounts of ISF (5–1250 mg/kg diet) for 70, 190, or 310 d. In Expt. 2, weanling Sprague-Dawley rats were fed diets containing 20% casein with or without supplemental ISF (50 mg/kg diet) or increasing amounts of alcohol-washed SPI (5, 10, and 20%) for 90 d. Intake of soy proteins significantly elevated hepatic RARß2 protein content dose-dependently compared with a casein diet, whereas supplemental ISF had no consistent effect. Neither RARß protein in the other tissues measured nor the other RAR (RAR{alpha} and RAR{gamma}) in the liver were affected by dietary SPI, indicating a tissue and isoform-specific effect of SPI. RARß2 mRNA abundances were not different between dietary groups except that its expression was markedly suppressed in male rats fed SPI for 310 d. DNA binding activity of nuclear RARß was significantly attenuated and the isoelectric points of RARß2 were shifted by dietary SPI. Overall, these results show for the first time, to our knowledge, that dietary soy proteins affect hepatic RARß2 protein content and RARß DNA binding activity, which may contribute to the suppression of retinoid-induced hypertriglyceridemia by SPI as reported.


   Introduction
TOP
 ABSTRACT
 Introduction
Materials and Methods
 Results
 Discussion
 LITERATURE CITED
 
Soy intake has been shown to be hypotriglyceridemic in both animals (1–3) and hyperlipidemic human subjects (4). This action of soy components has been further confirmed in our recent rat study showing dietary alcohol-washed soy protein isolate (SPI)6 containing minimal isoflavones (ISF) remarkably decreased plasma triacylglycerol levels (5). Furthermore, we previously reported that diets containing SPI significantly increased the hepatic thyroid hormone receptor (TR) ß1 protein content and suppressed the DNA binding activity of nuclear TR proteins (6,7). Retinoic acid receptors (RAR) are also members of the nuclear receptor superfamily and can form heterodimers with TR to interact with the target genes (8). However, whether soy intake affects RAR gene expression and function is unknown.

RA is a metabolite of vitamin A and plays important roles in controlling immune function, reproduction, cell growth, differentiation (9), and lipid metabolism (10,11). RA is important in the prevention and treatment of various cancers (12,13). For instance, loss of hepatic RA function leads to development of steatohepatitis and liver tumors (14). Most of the physiological functions of RA are mediated through RAR and altered RAR activity or RAR-mediated pathway is associated with many types of carcinogenesis (15–18). Three types of RAR (RAR{alpha}, RARß, and RAR{gamma}) have been characterized (19,20) and are encoded by independent genes. Several isoforms are generated from each gene by alternative splicing or usage of distinct promoters (21–23). For example, RARß has 4 isoforms (RARß1, RARß2, RARß3, and RARß4) that are generated by alternative gene splicing of primary transcripts initiated from 2 promoters, P1 and P2 (23,24).

Retinoids have been extensively used in the treatment of various cancers (25–27). However, one of the major adverse effects of retinoid treatment is the induction of hypertriglyceridemia, which has been observed in both rats (28) and humans (12,29–31). Interestingly, replacement of dietary casein with SPI markedly reduced the severity of RA-induced hypertriglyceridemia in rats (10,32). Nevertheless, the underlying mechanism(s) is not well understood. It has been shown that dietary SPI had no effect on serum retinoid level in RA-treated rats compared with the casein control (32) and that retinoid-induced hypertriglyceridemia is mediated through retinoid receptors (10,33). This suggests that SPI may exert its suppressive actions on the retinoid-induced hypertriglyceridemia via modulation of RAR or RAR-regulated gene expression. The objective of this study was to examine if dietary SPI and soy-derived ISF affect hepatic RAR gene expression and DNA binding ability in rats.


   Materials and Methods
TOP
 ABSTRACT
 Introduction
 Materials and Methods
Results
 Discussion
 LITERATURE CITED
 
    Chemicals and reagents. Alcohol-washed SPI (Pro Fam 930 containing 90% protein) and Novasoy (soy ISF concentrate) were purchased from Archer Daniels Midland Company. Casein protein (90% total protein) was from ICN and Harlan Teklad. Acrylamide, N,N'-methylene-bis-acrylamide, ammonium persulfate, dithiothreitol, Tris, phenylmethylsulfonyl fluoride, maleic acid, boric acid, Nonidet P-40, and EDTA were from Sigma Chemical. Western blotting detection kits and Hybond-N+ Membrane were obtained from Amersham. Goat anti-rabbit and anti-mouse immunoglobulin G (H+L)- horseradish peroxidase (HRP) conjugated antibodies, and Bio-Rad protein assay kits were purchased from Bio-Rad Laboratories. X-ray film was from MJS Biolynx. Affinity purified rabbit polyclonal antibodies against human RAR{alpha}, RARß, and mouse monoclonal antibody against human RAR{gamma} were from Santa Cruz Biotechnology and all tested to cross-react with rat antigens. RARß antibody was shown to detect both RARß1 and RARß2 isoforms. Biotin 3' End DNA Labeling kit and LightShift Chemiluminescent electrophoretic mobility shift assay kit were from Pierce Biotechnology.

    Animals, diets, and tissue samples. The animal experimental protocol was approved by the Health Canada Animal Care Committee and all animal handling and care followed the guidelines of the Canadian Council for Animal Care. Expt. 1 was designed to examine the effect of alcohol-washed SPI (containing minimal amount of ISF) and increasing amounts of added soy ISF using casein as a control. Briefly, Sprague-Dawley male and female rats (Charles River) at age of 50 d were randomly divided into 6 groups and fed one of the 6 diets as previously described (6) (Diet 1: 20% casein; Diet 2: 20% alcohol-washed SPI; Diets 3–6: 20% SPI supplemented with 5, 50, 250, or 1250 mg ISF/kg diet) for 70, 190, or 310 d. At the end of each feeding period, 10 male and 10 female rats per dietary group were killed for collection of tissues. Expt. 2 was to determine the effect of increasing amounts of alcohol-washed SPI and the residual ISF contained in the alcohol-washed SPI. Weanling Sprague-Dawley rats were randomly divided into 5 groups (8 males and 8 females per group) and fed 1 of the 5 diets for 90 d. All 5 diets were formulated according to the specifications for the AIN93G diet (34) except that L-cystine was replaced by L-methionine and in Diets 3–5, casein by equal amounts of alcohol-washed SPI (5, 10, and 20%). To determine the potential effect of remaining ISF in alcohol-washed SPI (31.7 mg/kg diet of 20% SPI), Diet 2 was supplemented with 50 mg/kg diet of ISF from Novasoy. The detailed dietary composition was reported elsewhere (7). At the end of feeding periods, rats were necropsied and the plasma and tissue samples were collected and stored at –80°C until analysis. The actual ISF content in each diet was determined by Waters HPLC linear gradient with UV detection monitored at 254 nm (35) and reported previously (6,7).

    Protein extraction and western-blot analysis. Total protein extraction and western-blot analysis were carried out as previously described (6) with minor modifications. Briefly, total proteins (80 µg) were resolved by 12% SDS-PAGE and electrotransferred (30 V, 4°C, overnight) onto nitrocellulose membranes. After blocking, membranes were incubated overnight at 4°C with primary antibodies and subsequently with HRP-conjugated secondary antibodies (1:5000) at room temperature for 45 min. Immunoreactivity was detected by chemiluminescence autoradiography in accordance with the manufacturer's instructions and the images were scanned. The intensities of the protein bands of interest and the Ponceau-stained proteins were determined densitometrically using Scion Image software. The intensities of the target proteins were normalized by the respective Ponceau-stained total protein (36).

    RARß mRNA quantification. Total RNA was isolated from rat liver samples with TRIzol reagent (Life Technologies). Five hundred nanograms of total RNA were reverse transcribed for cDNA synthesis using random primer oligonucleotides. One-tenth of the cDNA synthesized was then amplified with the following primers: rat RARß2 [forward: 5'-CTCTCAAAGCCTGCCTCAGT-3' (292–311), reverse: 5'-CTGTGCACTCCTGCTTTGAA-3' (702–683)] (GenBank accession number AJ002942) and universal 18S rRNA primers and competimers (Ambion) in a ratio of 2:8. PCR cycle conditions were 94°C for 5 min, 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min for 30 cycles, 72°C for 10 min. Samples were resolved on 2% agarose gels and visualized with ethidium bromide. The images were taken using BioDoc-It Imaging System (UVP Inc.) and analyzed with Scion Image software. RARß2 mRNA levels were normalized against their respective 18S rRNA content.

    Two-dimensional western-blot analysis of RARß. Two-dimensional (2D) gel electrophoresis was carried out according to the method of O'Farrell (37). Briefly, liver total proteins (200 µg) pooled from 3 rats fed the same diets were subjected to isoelectric focusing in 2% glass tube gels of pH 3.5–10 (Amersham Pharmacia Biotech). After equilibration, the tube gels were sealed to the top of stacking gels on top of 10% acrylamide slab gels and run for ~4 h. The gel was transblotted onto polyvinylidene difluoride membrane overnight and stained with Coomassie Blue. The membranes were immunostained with rabbit anti-human RARß polyclonal antibody (1:500 dilution) and detected using an emission of chemiluminescence kit.

    Nuclear protein preparation and electrophoretic mobility shift assay. Hepatic nuclear protein extracts were prepared as previously described (7). Double-stranded DNA oligonucleotides containing consensus sequences (5'-TCGAGGGTAGGGTTCACCGAAAGTTCACTCG-3') for RAR-specific binding was labeled at the 3'-end with biotin-N4-CTP and terminal deoxynucleotidyl transferase. Nuclear protein extracts (2 µg) were incubated with biotin-labeled DNA probes in the binding buffer for 15 min at room temperature. DNA-protein complexes were resolved on a native 6% polyacrylamide gel in Tris-buffered EDTA (pH 8.0) and electrotransferred (80 V for 1.5 h) onto positively charged nylon membranes. The biotin-labeled DNA probes bound to the nuclear proteins were immunostained with streptavidin-HRP conjugate and detected by chemiluminescence autoradiography. The binding specificity of RARß to DNA probe was determined by cold probe (100x) competition and supershifting with 1 µg rabbit anti-human RARß antibody. The intensity of the specific nuclear protein band was densitometrically determined and normalized by the amount of total probe (bound + free).

    Statistical analyses. Results are expressed as means ± SEM. Effects of treatment on hepatic RARß2 protein content and mRNA steady-state abundances were analyzed by 2-way ANOVA, which included the main effects of diet and feeding duration as well as interaction of diet x feeding duration. All the other data presented were analyzed by 1-way ANOVA. The males and females were analyzed separately. Differences between individual means were determined by Fisher's least significant difference test. A probability of P < 0.05 was considered significant. Data were analyzed using STATISTICA Version 7.1 (StatSoft).


   Results
TOP
 ABSTRACT
 Introduction
 Materials and Methods
 Results
Discussion
 LITERATURE CITED
 
    Hepatic total and nuclear RARß protein content. Consumption of 20% alcohol-washed SPI in the absence of supplemental ISF for 70 d markedly increased hepatic RARß protein content in both female and male rats compared with a casein-based diet (Fig. 1A,B; P < 0.01) . Supplementation of increasing amounts of ISF to 20% alcohol-washed SPI-based diet had no additional effect on RARß content compared with SPI alone (P > 0.05; Fig. 1A,B) except that addition of 5 or 1250 mg ISF/kg diet slightly elevated RARß levels in female rats (Fig. 1A). Dietary SPI significantly increased hepatic RARß protein content at all 3 time points (for 70, 190, and 310 d) examined in both female and male rats compared with a casein-based diet (Fig. 1C,D). However, neither SPI nor ISF had any effect on RAR{alpha} or RAR{gamma} (data not shown).


Figure 1
View larger version (41K):
[in this window]
[in a new window]

  		Figure 1  Hepatic total RARß protein content in the female (A, C) and male (B, D) rats fed diets containing 20% casein or 20% alcohol-washed SPI with or without increasing amounts of supplemental ISF (5, 50, 250, or 1250 mg/kg diet) for 70 d or fed diets containing 20% casein (Ca) or 20% alcohol-washed SPI (S) for 70, 190, and 310 d. The images shown are representative of 3 replicates. Values are means ± SEM, n = 3. Means without a common letter differ, P < 0.01.

 
Intake of increasing amounts of alcohol-washed SPI (5, 10, and 20%) for 90 d markedly elevated hepatic nuclear RARß protein content in a dose-dependent manner in both sexes (Fig. 2A,B). Addition of ISF (50 mg ISF/kg diet) to the casein-based diet had no effect on hepatic nuclear RARß protein content.


Figure 2
View larger version (25K):
[in this window]
[in a new window]

  		Figure 2  Hepatic nuclear RARß protein content in the female (A) and male (B) rats fed diets containing 20% casein in the absence or presence of supplemental ISF (50 mg/kg diet) or increasing amounts of alcohol-washed SPI (5, 10, or 20%) for 90 d. The images shown are representative of 3 replicates. Values are means ± SEM, n = 3. Means without a common letter differ, P < 0.01.

 
    Hepatic RARß mRNA abundance. Hepatic RARß mRNA steady-state levels measured by relative semiquantitative reverse transcription-PCR did not differ between dietary groups in female rats (data not shown). Consumption of 20% alcohol-washed SPI decreased RARß mRNA abundance in the male rats fed for 310 d (P < 0.01; Fig. 3B) but had no effect at earlier time points measured (70 and 190 d).


Figure 3
View larger version (27K):
[in this window]
[in a new window]

  		Figure 3  Hepatic RARß mRNA abundance in the male rats fed 20% casein (Ca) or 20% alcohol-washed SPI (S) for 70, 190, or 310 d. The images shown are a representative of 3 replicates. Values are means ± SEM, n = 3. Means without a common letter differ, P < 0.01.

 
    Isoelectric points of the hepatic RARß proteins. Intensities of most protein spots in the 3 Coomassie Blue-stained 2D images (Fig. 4A,C,E) were similar, indicating even loading and transfer. Two spots with a molecular weight of 51 kDa were immunostained with RARß antibody in the liver proteins of the casein-fed male rats. Their isoelectric points (pIs) were 7.20 and 7.48, respectively (Fig. 4B). Interestingly, in addition to these spots, 2 more spots with the same molecular weight but different pIs (6.59 and 6.88) were detected in the liver samples from SPI-fed rats (Fig. 4D,F). Similar results were obtained in the female rats (data not shown).


Figure 4
View larger version (77K):
[in this window]
[in a new window]

  		Figure 4  2D western-blot analysis of hepatic RARß protein in the male rats fed diets containing either 20% casein (A, B) or 20% alcohol-washed SPI in the absence (SPI; C, D) or presence (SPI+ISF; E and F) of supplemental ISF (250 mg/kg diet) for 70 d. The pI were calculated using a linear regression of pI and the location (distance) of the protein on the 2D gel, which was established with an internal standard of a known pI. The arrows in (D) and (F) represent the RARß protein with changed pI.

 
    Hepatic RARß DNA binding activity. Three bands were detected in the liver samples, which may represent different forms of RAR complexes (i.e. homodimers and heterodimers). Addition of a 100-fold excess of unlabeled DNA oligonucleotide probe (cold probe) eliminated all the binding activity of the 2 lower bands and reduced the abundance of the top band (lanes 6 and 12 vs. lanes 2 and 8, respectively; Fig. 5), indicating the 2 lower bands and part of the top band are RAR-specific binding complex. Supershifting analysis showed that the 2 lower bands but not the top one were shifted by RARß antibody (lanes 5 and 11). Nuclear RARß DNA binding abilities in both male and female rats fed diets containing either 5% (lanes 3 and 9) or 20% (lanes 4 and 10) SPI were lower than in those fed the casein diet (lanes 2 and 8; P < 0.05).


Figure 5
View larger version (65K):
[in this window]
[in a new window]

  		Figure 5  DNA binding activity of hepatic nuclear RAR in rats fed diets containing either 20% casein (lanes 2 and 8) or 5% (lanes 3 and 9) or 20% (lanes 4 and 10) alcohol-washed SPI for 90 d. The binding specificity was determined by cold probe competition (100x) (lanes 6 and 12) and supershifting with rabbit anti-human RARß polyclonal antibody (lanes 5 and 11). The images shown are representatives of 3 replicates of each.

 
    Tissue distribution of RARß proteins. Distinct RARß isoforms were expressed in different tissues of both female (Fig. 6) and male (data not shown) rats. The 51-kDa RARß2 protein was the predominant isoform in the liver and remarkably increased by dietary SPI compared with casein. In kidney and heart, the predominant form was RARß4 (48 kDa) and was unchanged by the diets (Fig. 6A). RARß2 protein content was very low in thyroid tissue and was not different between dietary groups (Fig. 6B).


Figure 6
View larger version (42K):
[in this window]
[in a new window]

  		Figure 6  Total RARß protein content in liver, thyroid, kidney, and heart (A) of the female rats fed diets containing either 20% casein or 20% alcohol-washed SPI for 70 d. The image shown in (A) is a representative of 3 replicates. RARß2 expression in thyroid was further analyzed separately (B).

 

   Discussion
TOP
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
LITERATURE CITED
 
In this study, we showed that consumption of alcohol-washed SPI (containing minimal amount of ISF) significantly elevated hepatic RARß2 protein content in both male and female rats. This effect was further demonstrated to be dose dependent. However, the protein content of the other RAR, including RAR{alpha} and RAR{gamma}, did not differ among dietary groups, indicating that the effect of SPI is RAR isoform-specific. Supplementation with increasing amounts of soy-derived ISF to SPI-based diets had no consistent additional effect.

Although the SPI used in this study was subjected to alcohol extraction to remove the associated ISF, a minimal level of ISF (~31.7 mg/kg diet) remained in the diet containing 20% SPI. Soy ISF, especially the major component genistein, are capable of modulating RARß gene expression in various cancer cells via inhibition of DNA methyltransferase activity (38). This may imply that the effect of SPI observed could be a result of ISF contamination. To exclude this possibility, we added a similar amount of ISF (42.8 mg/kg diet) from Novasoy to the casein-based diet in Expt. 2. The results showed that added ISF had no significant effect (P > 0.05) on the nuclear RARß2 protein in the liver, confirming that SPI rather than ISF accounts for the increase in hepatic RARß2 protein.

To understand the potential underlying molecular event(s) by which SPI elevated hepatic RARß2 protein content, we further measured the RARß2 mRNA steady-state levels and found that dietary SPI failed to upregulate the RARß2 gene expression throughout the feeding periods. In contrast, the long-term feeding (310 d) of the rats with the SPI-based diet decreased the RARß2 mRNA abundances in the liver compared with the casein diet. This indicates that modulation of hepatic RARß2 protein content by SPI might be post-transcriptional. This notion was supported by the evidence obtained from 2D western-blot analysis showing that the rats fed SPI-based diets have 2 unique hepatic proteins with the same molecular weight (51 kDa) as RARß2 but different pIs. These proteins cross reacted with rabbit anti-human RARß antibody, suggesting that they might be modified forms of RARß2 protein.

This study showed that dietary SPI markedly suppressed the binding activity of the hepatic nuclear RARß to the consensus DNA sequence of target genes. Binding of the nuclear receptors to the ligand response elements of the promoter region in the target genes is essential for the regulation of downstream gene expression and critical for the receptor-mediated functions. Thus, inhibition of RARß function (i.e. DNA binding activity) is believed to play a pivotal role in mediating the previously reported suppressive actions of SPI on retinoid-induced hyperglyceridemia that was shown to be mediated through RAR (10).

We further demonstrated that nuclear content of RARß2 protein was also consistently elevated in both male and female rats by dietary SPI (Fig. 2). This suggests that modification of RARß2 protein by SPI may affect only the DNA binding ability but not the translocation of the receptor into nucleus. RARß protein content in the other tissues examined were not affected by dietary SPI in this study, indicating that the effects of soy protein are liver specific. Liver plays important roles in the uptake, storage, and mobilization of retinol and stores up to 80% of the body retinoids (39). In addition, RARß2 is the most abundant RARß isoform in the body (40). Suppression of hepatic RARß function by soy components may have impacts on vitamin A function and RARß-regulated gene expression and activities. RARß has been identified as a tumor suppressor (41–44) and silenced or reduced RARß gene expression is closely associated with tumorigenesis (13,18,45). Whether the inhibition of RARß DNA binding ability induced by soy components in the liver is related to any type of carcinogenesis warrants further investigation.

Although the exact molecular mechanism(s) by which soy components elevated the hepatic RARß2 protein level and suppressed RARß DNA binding activity is not understood, it is believed that post-translational modification of RARß2 protein may play a key role in this regard. Phosphorylation is one of the most common protein modifications in animal cells (46). It has been shown that phosphorylation of serine and/or threonine in proteins such as soluble CD44, the principal hyaluronic acid receptor (47), and rat valosin-containing protein (48) resulted in acidic shift in their pIs, an effect observed in hepatic RARß2 of the rats fed SPI in this study. Moreover, phosphorylation is known to be an important mechanism regulating the transactivation and degradation of RAR (49). Particularly, the phosphorylation of RAR{alpha} has been extensively studied and several kinases including Akt and c-Jun N-terminal kinase have been shown to be involved in these processes. For example, Akt phosphorylates the Ser-96 residue of RAR{alpha} DNA-binding domain and inhibits its transactivation (49). c-Jun N-terminal kinase phosphorylates RAR{alpha} at residues Thr-181, Ser-445, and Ser-461, resulting in RAR dysfunction and degradation through the ubiquitin-proteasomal pathway (50). In addition, several components of soy, including soybean trypsin inhibitors, ISF (genistein), and their metabolite, equol, have been shown to affect phosphorylation status of proteins and enzymes (51–53).

It was suggested that a higher arginine-to-lysine ratio in soy may be responsible for its lipid-lowering actions, because the addition of arginine to a casein-based diet reduced the severity of retinoid-induced hypertriglyceridemia, but not as effectively as replacing casein with soy protein (54). More recent evidence indicates that ß-conglycinin, one of the major soybean storage proteins, may contain the bioactive peptide responsible for the hypolipidemic effects of soy (2,55–57).

In summary, this study demonstrates for the first time, to our knowledge, that intake of alcohol-washed SPI markedly increased hepatic RARß2 protein content and suppressed the binding ability of the nuclear RARß to the consensus DNA sequence of target genes in rats. The RARß2 mRNA abundance was not increased by dietary SPI. The pIs of the hepatic RARß2 protein demonstrated that more acidic isoforms were prevalent in rats ingesting SPI. These results suggest that dietary SPI may exert its effect through post-translational modification such as phosphorylation on the RARß2 protein, thereby changing its structure or conformation and affecting the protein degradation (or stability) and DNA binding activity of RARß. However, this remains to be confirmed. Our ongoing studies include determination of the type of protein modifications in a variety of proteins in response to dietary SPI. Further work is required to identify the bioactive component(s) in soy and their effects on protein degradation using appropriate models.


   FOOTNOTES
 
1 Supported by Health Canada. Back

2 This is publication no. 610 of the Bureau of Nutritional Sciences. Back

6 Abbreviations used: HRP, horseradish peroxidase; ISF, isoflavone; pI, isoelectric point; RAR, retinoic acid receptor; SPI, soy protein isolate; TR, thyroid hormone receptor; 2D, 2-dimensional. Back

Manuscript received 1 September 2006. Initial review completed 26 September 2006. Revision accepted 13 October 2006.


   LITERATURE CITED
TOP
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 LITERATURE CITED
 

1. Lin Y, Meijer GW, Vermeer MA, Trautwein EA. Soy protein enhances the cholesterol-lowering effect of plant sterol esters in cholesterol-fed hamsters. J Nutr. 2004;134:143–8.[Abstract/Free Full Text]

2. Moriyama T, Kishimoto K, Nagai K, Urade R, Ogawa T, Utsumi S, Maruyama N, Maebuchi M. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem. 2004;68:352–9.[Medline]

3. Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, Tovar AR. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr. 2004;134:522–9.[Abstract/Free Full Text]

4. Wang Y, Jones PJ, Ausman LM, Lichtenstein AH. Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis. 2004;173:269–75.[Medline]

5. Xiao CW, Wood C, Huang W, L'Abbe MR, Gilani GS, Cooke GM, Curran I. Tissue-specific regulation of acetyl-CoA carboxylase gene expression by dietary soya protein isolate in rats. Br J Nutr. 2006;95:1048–54.[Medline]

6. Xiao CW, L'Abbe MR, Gilani S, Cooke G, Curran I, Papademetriou SA. Dietary soy protein isolate and isoflavones modulate hepatic thyroid hormone receptors in rats. J Nutr. 2004;134:743–9.[Abstract/Free Full Text]

7. Huang W, Wood C, L'Abbe MR, Gilani S, Cockell KA, Xiao CW. Soy protein isolate increases hepatic thyroid hormone receptor content and inhibits its binding to the target genes in rats. J Nutr. 2005;135:1631–5.[Abstract/Free Full Text]

8. Lee S, Privalsky ML. Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties. Mol Endocrinol. 2005;19:863–78.[Abstract/Free Full Text]

9. Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr. 2004;24:201–21.[Medline]

10. Standeven AM, Beard RL, Johnson AT, Boehm MF, Escobar M, Heyman RA, Chandraratna RA. Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors. Fundam Appl Toxicol. 1996;33:264–71.[Medline]

11. Villarroya F, Iglesias R, Giralt M. Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes. Curr Med Chem. 2004;11:795–805.[Medline]

12. Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, Giordano C, Benazzo M, Caroggio A, et al. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep. 2004;11:1297–305.[Medline]

13. Petty WJ, Li N, Biddle A, Bounds R, Nitkin C, Ma Y, Dragnev KH, Freemantle SJ, Dmitrovsky E. A novel retinoic acid receptor {beta} isoform and retinoid resistance in lung carcinogenesis. J Natl Cancer Inst. 2005;97:1645–51.[Abstract/Free Full Text]

14. Shiota G. Loss of function of retinoic acid in liver leads to steatohepatitis and liver tumor: a NASH animal model. Hepatol Res. 2005;33:155–60.[Medline]

15. Darwiche N, Scita G, Jones C, Rutberg S, Greenwald E, Tennenbaum T, Collins SJ, De Luca LM, Yuspa SH. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression. Cancer Res. 1996;56:4942–9.[Abstract/Free Full Text]

16. Marshall GM, Cheung B, Stacey KP, Camacho ML, Simpson AM, Kwan E, Smith S, Haber M, Norris MD. Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Oncogene. 1995;11:485–91.[Medline]

17. de The H. Altered retinoic acid receptors. FASEB J. 1996;10:955–60.[Abstract]

18. Wang Y, Fang MZ, Liao J, Yang GY, Nie Y, Song Y, So C, Xu X, Wang LD, et al. Hypermethylation-associated inactivation of retinoic acid receptor {beta} in human esophageal squamous cell carcinoma. Clin Cancer Res. 2003;9:5257–63.[Abstract/Free Full Text]

19. Krust A, Kastner P, Petkovich M, Zelent A, Chambon P. A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci USA. 1989;86:5310–4.[Abstract/Free Full Text]

20. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996;10:940–54.[Abstract]

21. Kastner P, Krust A, Mendelsohn C, Garnier JM, Zelent A, Leroy P, Staub A, Chambon P. Murine isoforms of retinoic acid receptor gamma with specific patterns of expression. Proc Natl Acad Sci USA. 1990;87:2700–4.[Abstract/Free Full Text]

22. Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier JM, Kastner P, Dierich A, Chambon P. Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. EMBO J. 1991;10:59–69.[Medline]

23. Zelent A, Mendelsohn C, Kastner P, Krust A, Garnier JM, Ruffenach F, Leroy P, Chambon P. Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. EMBO J. 1991;10:71–81.[Medline]

24. Nagpal S, Zelent A, Chambon P. RAR-{beta}4, a retinoic acid receptor isoform is generated from RAR-{beta}2 by alternative splicing and usage of a CUG initiator codon. Proc Natl Acad Sci USA. 1992;89:2718–22.[Abstract/Free Full Text]

25. Yamauchi T, Arai H, Taga M, Amaya N, Lee JD, Ueda T. Adams-Stokes attack due to complete atrioventricular block in a patient with acute promyelocytic leukemia during remission induction therapy using all-trans retinoic acid. Rinsho Ketsueki. 2005;46:206–10.[Medline]

26. Berg G, Andersson T, Sjodell L, Jansson S, Nystrom E. Development of severe thyroid-associated ophthalmopathy in a patient with disseminated thyroid cancer treated with recombinant human thyrotropin/radioiodine and retinoic acid. Thyroid. 2005;15:1389–94.[Medline]

27. Stadler R, Kremer A. Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids. Semin Oncol. 2006;33:S7–10.[Medline]

28. Gerber LE, Erdman JW Jr. Hyperlipidemia in rats fed retinoic acid. Lipids. 1981;16:496–501.[Medline]

29. Marsden JR. Effect of dietary fish oil on hyperlipidaemia due to isotretinoin and etretinate. Hum Toxicol. 1987;6:219–22.[Medline]

30. Marsden JR, Trinick TR, Laker MF, Shuster S. Effects of isotretinoin on serum lipids and lipoproteins, liver and thyroid function. Clin Chim Acta. 1984;143:243–51.[Medline]

31. Cartmel B, Dziura J, Cullen MR, Vegso S, Omenn GS, Goodman GE, Redlich CA. Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET). Eur J Clin Nutr. 2005;59:1173–80.[Medline]

32. Radcliffe JD, Imrhan VL, Hsueh AM. The use of soy protein isolate to reduce the severity of 13-cis retinoic acid-induced hypertriglyceridemia. Cancer Detect Prev. 1998;22:526–32.[Medline]

33. Vu-Dac N, Gervois P, Torra IP, Fruchart JC, Kosykh V, Kooistra T, Princen HM, Dallongeville J, Staels B. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids. J Clin Invest. 1998;102:625–32.[Medline]

34. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–51.[Abstract/Free Full Text]

35. Wang HJ, Murphy P. Isoflavone content in commercial soybean foods. J Agric Food Chem. 1994;42:1666–73.

36. Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein. Endocrinology. 2003;144:623–30.[Abstract/Free Full Text]

37. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250:4007–21.[Abstract/Free Full Text]

38. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res. 2005;11:7033–41.[Abstract/Free Full Text]

39. Biesalski HK, Nohr D. New aspects in vitamin A metabolism: the role of retinyl esters as systemic and local sources for retinol in mucous epithelia. J Nutr. 2004;134:S3453–7.[Abstract/Free Full Text]

40. Xu XC, Lee JJ, Wu TT, Hoque A, Ajani JA, Lippman SM. Increased retinoic acid receptor-{beta}4 correlates in vivo with reduced retinoic acid receptor-{beta}2 in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2005;14:826–9.[Abstract/Free Full Text]

41. Hoffman AD, Engelstein D, Bogenrieder T, Papandreou CN, Steckelman E, Dave A, Motzer RJ, Dmitrovsky E, Albino AP, et al. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. Clin Cancer Res. 1996;2:1077–82.[Abstract]

42. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol. 1996;16:1138–49.[Abstract/Free Full Text]

43. Kaiser A, Herbst H, Fisher G, Koenigsmann M, Berdel WE, Riecken EO, Rosewicz S. Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells. Gastroenterology. 1997;113:920–9.[Medline]

44. Lefebvre B, Brand C, Flajollet S, Lefebvre P. Down-regulation of the tumor suppressor gene RAR{beta}2 through the PI3K/Akt signaling pathway. Mol Endocrinol. 2006;20:2109–21.[Abstract/Free Full Text]

45. Rochaix P, Monteil-Onteniente S, Rochette-Egly C, Caratero C, Voigt JJ, Jozan S. Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: immunohistochemical and western blot study. Histopathology. 1998;33:337–43.[Medline]

46. Pagliarini DJ, Dixon JE. Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem Sci. 2006;31:26–34.[Medline]

47. Knepper PA, Miller AM, Choi J, Wertz RD, Nolan MJ, Goossens W, Whitmer S, Yue BY, Ritch R, et al. Hypophosphorylation of aqueous humor sCD44 and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005;46:2829–37.[Abstract/Free Full Text]

48. Klein JB, Barati MT, Wu R, Gozal D, Sachleben LR Jr, Kausar H, Trent JO, Gozal E, Rane MJ. Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins. J Biol Chem. 2005;280:31870–81.[Abstract/Free Full Text]

49. Srinivas H, Xia D, Moore NL, Uray IP, Kim H, Ma L, Weigel NL, Brown PH, Kurie JM. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. Biochem J. 2006;395:653–62.[Medline]

50. Srinivas H, Juroske DM, Kalyankrishna S, Cody DD, Price RE, Xu Xc, Narayanan R, Weigel NL, Kurie JM. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor {alpha}. Mol Cell Biol. 2005;25:1054–69.[Abstract/Free Full Text]

51. Liu D, Homan LL, Dillon JS. Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5'-monophosphate-dependent mechanism. Endocrinology. 2004;145:5532–9.[Abstract/Free Full Text]

52. Inagaki K, Kobayashi H, Yoshida R, Kanada Y, Fukuda Y, Yagyu T, Kondo T, Kurita N, Kitanaka T, et al. Suppression of urokinase expression and invasion by a soybean Kunitz trypsin inhibitor are mediated through inhibition of Src-dependent signaling pathways. J Biol Chem. 2005;280:31428–37.[Abstract/Free Full Text]

53. Joy S, Siow RC, Rowlands DJ, Becker M, Wyatt AW, Aaronson PI, Coen C, Jacob R, Kallo I, et al. The isoflavone equol mediates rapid vascular relaxation: Ca2+-independent activation of eNOS/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J Biol Chem. 2006;281:27335–45.[Abstract/Free Full Text]

54. Radcliffe JD, Czajka-Narins DM. Use of arginine to reduce the severity of retinoid-induced hypertriglyceridemia. Nutr Cancer. 2000;36:200–6.[Medline]

55. Aoyama T, Kohno M, Saito T, Fukui K, Takamatsu K, Yamamoto T, Hashimoto Y, Hirotsuka M, Kito M. Reduction by phytate-reduced soybean beta-conglycinin of plasma triglyceride level of young and adult rats. Biosci Biotechnol Biochem. 2001;65:1071–5.[Medline]

56. Duranti M, Lovati MR, Dani V, Barbiroli A, Scarafoni A, Castiglioni S, Ponzone C, Morazzoni P. The alpha' subunit from soybean 7S globulin lowers plasma lipids and upregulates liver beta-VLDL receptors in rats fed a hypercholesterolemic diet. J Nutr. 2004;134:1334–9.[Abstract/Free Full Text]

57. Fukui K, Kojima M, Tachibana N, Kohno M, Takamatsu K, Hirotsuka M, Kito M. Effects of soybean beta-conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats. Biosci Biotechnol Biochem. 2004;68:1153–5.[Medline]




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
R. W Friesen and S. M Innis
Linoleic acid is associated with lower long-chain n-6 and n-3 fatty acids in red blood cell lipids of Canadian pregnant women
Am. J. Clinical Nutrition, January 1, 2010; 91(1): 23 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
B. Bermudez, S. Lopez, Y. M. Pacheco, J. Villar, F. J.G. Muriana, J. D. Hoheisel, A. Bauer, and R. Abia
Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery
Cardiovasc Res, July 15, 2008; 79(2): 294 - 303.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. W. Xiao
Health Effects of Soy Protein and Isoflavones in Humans
J. Nutr., June 1, 2008; 138(6): 1244S - 1249S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. M Innis and R. W Friesen
Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 548 - 557.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H. Eutamene and L. Bueno
Role of probiotics in correcting abnormalities of colonic flora induced by stress
Gut, November 1, 2007; 56(11): 1495 - 1497.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
J. L. Pongrac, P. J. Slack, and S. M. Innis
Dietary Polyunsaturated Fat that Is Low in (n-3) and High in (n-6) Fatty Acids Alters the SNARE Protein Complex and Nitrosylation in Rat Hippocampus
J. Nutr., August 1, 2007; 137(8): 1852 - 1856.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, C. W.
Right arrow Articles by Curran, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, C. W.
Right arrow Articles by Curran, I. H.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2007 by American Society for Nutrition